Cryopreservation Equipment Market

Cryopreservation Equipment Market, by Equipment,
Cryogen, Application, End User and by Geography Global Trends and Forecast to 2025
Cryopreservation is a process of maintaining biological samples in a form of suspended state at
cryogenic temperature for considerable period and is used to preserve the fine structure of cells.
Through this process, samples of cells, tissues, and organelles are cooled at very low
temperatures (less than -2130F), for preservation. Cryopreservation is primarily used in the
preservation of oocytes and embryos with in-vitro fertilization (IVF) cycle, prior to
chemotherapy for women diagnosed with breast cancer, in order to preserve their reproductive
capacity. Moreover, frozen embryos are found to provide similar results as fresh embryos. For
instance, according to the Assisted Reproductive Technology in Australia and New Zealand 2013
report published by UNSW's National Perinatal Epidemiology and Statistics Unit (NPESU), over
25% increase has been recorded in the birth rate associated with frozen embryo transfers over
the last five years, rising from 18% to 23%. Additionally, IVF treatments using frozen embryos
increased from 39% of IVF cycles in 2009 to 45% of cycles in 2013. Linde LLC introduced its
new CRYOLINE CWI CRYOWAVE impingement freezer at the International Production &
Processing Expo (IPPE) in Atlanta, in January 2018. Company’s new product combines the
benefits of CRYOWAVE product agitation with cryogenic gas impingement flows, which utilizes
liquid nitrogen to freeze products.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1356
The global cryopreservation equipment market is estimated to be valued at US$ 4,318.1 million
in 2017 and is expected to witness a CAGR of 13.2% over the forecast period (2017–2025)
Market Dynamics:
Growing advancements in cord-cell preservation, long-term preservation of pluripotent stem
cells, bone marrow, and umbilical cord blood preservation, to obtain multiple regenerative and
tissue engineering application, is driving growth of the cryopreservation equipment market.
Stem cells are specialized cells capable of being regenerated through cell division and
differentiated into multi-lineage cells. Mesenchymal stem cells (MSCs) are adult stem cells,
which have multi-lineage potential, immunomodulation, and are capable of secreting antiinflammatory molecules, thus proving to be an effective tool in the treatment of chronic
diseases. Moreover, the increasing burden of chronic diseases such as arthritis, stroke, cancer,
diabetes and among others and growing trend of cryopreserving human mesenchymal stem cells
are expected to boost demand for cryopreservation equipment. For instance, according to the
Centers for Disease Control and Prevention (CDC), seven of the top causes of deaths in 2014,
were due to chronic diseases, with cancer and cardiovascular diseases accounting for around
46% of the all deaths in 2014, worldwide.
Increasing number of government initiatives for preservation of stem cells is expected to
augment market growth:
New York Blood Center (NYBC) initiated the National Cord Blood Program, in 1992, to
investigate, collect, process, freeze, and store the cord blood cells in liquid nitrogen freezers,
which are used when patients with hematopoietic transplants are unable to find compatible
bone marrow donors. NCBP is the first and largest cord bank in the world, which recorded a
collection of over 60,000 cord blood units, till 2016. NCBP has provided cord blood units for
transplantation to over 4,900 recipients, throughout the world. Additionally, in 2011, Canada’s
Ministry of Health, initiates Canada’s first national, publicly funded umbilical cord blood bank,
which aims to provide the donations for the allogeneic hematopoietic stem cell transplant.
North America market accounted for the largest market share, followed by Europe in 2016. This
is owing to the major collaboration and agreement of key players in the cryopreservation
equipment manufacturing. In June 2016, Cryogenic Control made a distribution agreement with
Paramount Gas Products and Cryo Inc. According to this agreement, Paramount Gas Products
and Cryo Inc. will become the official distributors of Cryogenic Control’s first product, ELLN2
in North America. The agreement allows the Paramount Gas Products and Cryo Inc. to
distribute the ELLN2 in certain major states of North America.
Report includes chapters which deeply display the following deliverable about industry :
• Cryopreservation Equipment Market Research Objective and Assumption
• Cryopreservation Equipment Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Cryopreservation Equipment Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cryopreservation Equipment Market, By Regions
• Cryopreservation Equipment Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Cryopreservation Equipment Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Cryopreservation Equipment Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cryopreservation Equipment Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Competative Analysis:
Some of the key players operating in the global cryopreservation equipment market are Thermo
Fisher Scientific, Inc., Custom Biogenic Systems, Chart Biomedical Co. Ltd., Merck KGaA,
Barber-Nichols Inc., Praxair Technology, Inc., Linde LLC, Planer PLC, Cryologic Pty. Ltd.,
Charter Medicals, Nikkiso Cryo Inc., Cryogenic Control, and Haimen United Laboratory
Equipment Development Co., Ltd.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1356
Market Taxonomy:
This report segments the global cryopreservation equipment market on the basis of equipment,
cryogen, application and end user segment. On the basis of equipment, the market is classified
into freezers, incubators, sample preparation systems and accessories. Freezers segment is
further sub-divided into cryopreservation freezers and drystore freezers. Accessories segment
further sub-divided into cryopreservation vials, freezer box, cryocart, cryogenic vaporizer and
other accessories. On the basis of cryogen, cryopreservation equipment market segmented into
liquid nitrogen, oxygen, argon, liquid helium. Applications of cryopreservation equipment
include cord blood stem cells, cord blood stem cells, embryos & oocytes and other applications.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Cryopreservation is a process of maintaining biological samples in a form of suspended state at cryogenic temperature for considerable period and is used to preserve the fine structure of cells.

Download Report